NCT04754399View on ClinicalTrials.gov

Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 16, 2021

Primary Completion Date

October 10, 2023

Study Completion Date

October 10, 2023

Conditions
ArthralgiaBreast Cancer
Interventions
DRUG

Cannabidiol (CBD)

"week 1: 25 mg twice daily, approximately 12 hours apart, with food~week 2: 50 mg twice daily, approximately 12 hours apart, with food~week 3: 75 mg twice daily, approximately 12 hours apart, with food~week 4+: 100 mg twice daily, approximately 12 hours apart, with food"

Trial Locations (1)

48109

University of Michigan Rogel Cancer Center, Ann Arbor

All Listed Sponsors
collaborator

American Society of Clinical Oncology

OTHER

lead

University of Michigan Rogel Cancer Center

OTHER